2 patients with to agree to cancel the prescription; Patients with severe DDIs are also discussed by pharmacists to agree on the most appropriate management for each patient, such as 77.83% of clinical supervision; 7.08% of replacement medicine; 2.83% of following up more tests; 1.89% of stopping using drugs.